Business Context and Reporting Period
This Form 6-K filing by China Internet Nationwide Financial Services Inc. (CIFS) covers the month of May 2018, specifically dated May 3, 2018. CIFS is a financial advisory services company headquartered in Beijing, China, serving primarily small-to-medium sized enterprises. The filing announces a strategic partnership involving its wholly owned subsidiary, Fu Hui (Shenzhen) Commercial Factoring Co., Ltd.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The primary financial metric disclosed is the size of a new credit facility:
- Revolving Factoring Credit Line: RMB 100 million (approximately $15.7 million).
- Counterparty: Sino Pharma Business Factoring Co., Ltd. (Sino Pharma BF).
- Collateral: Accounts receivable from Grade A hospitals with Class II or above rankings.
- Term: One year with options for multiple-year extensions.
Material Changes
The filing details a material expansion of CIFS's supply chain financing business, which was launched in October 2017. The signing of the revolving factoring credit facility with Sino Pharma BF represents a significant strategic development intended to advance this specific business line. No comparative financial data or changes in historical performance metrics are provided in this document.
Guidance, Outlook, and Risks
Management Commentary: Jianxin Lin, Chairman and CEO, stated that the partnership is a strategic priority expected to contribute significantly to financial performance in 2018 and beyond. The company views supply chain financing as a key growth area.
Forward-Looking Statements: The document contains standard forward-looking statements regarding future expectations, including the belief that the relationship will "bear fruit." Management cautions that actual results may differ materially due to unknown risks and uncertainties.
Risks: The filing references general risks associated with forward-looking statements and directs investors to other SEC filings for detailed risk factors. No specific new contingencies or unusual items are detailed beyond the standard legal disclaimers.
Investor Verification Checklist
- Verify the actual utilization rate of the RMB 100 million credit facility in subsequent quarterly reports.
- Confirm the credit quality and performance of the underlying accounts receivable from Grade A hospitals backing the facility.
- Review upcoming Form 20-F filings to assess the tangible impact of this partnership on CIFS's overall revenue and profitability.
- Monitor regulatory developments in China's factoring and healthcare financing sectors that could affect the facility's extension options.